MedTech News

Dundee Dermatology Now Offering Novel Brain Stimulation Device for Mental Wellness
WEST DUNDEE, Ill., Aug. 14, 2025 /PRNewswire/ — Those seeking help with depression or anxiety can now benefit from an FDA-cleared, medication-free procedure at Dundee Dermatology. The center is showcasing EXOMIND, a noninvasive neurostimulation device that enhances mental wellness.

Using generative AI, researchers design compounds that can kill drug-resistant bacteria
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.

FDA grants de novo authorisation to Artera’s prostate software
The test was previously granted a breakthrough device designation by the US regulator.

Apple updates smart watches with blood oxygen feature after customs ruling
Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

Portable test detects infections from a single drop of blood in 15 minutes
Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and reliably we detect illnesses like COVID-19, Ebola, AIDS or Lyme disease.

In-mouth hydrogel releases artificial saliva to treat dry mouth
Now, researchers publishing in ACS Applied Polymer Materials have created a reusable hydrogel that releases artificial saliva over time, which could help provide sustained relief from dry mouth.

AI tools and datasets point to tailored treatments for kidney disease patients
Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School of Medicine and the Wharton School at the University of Pennsylvania can analyze kidney disease at the cellular level to match the most effective treatments and speed up solutions.

Scientists develop off-the-shelf immunotherapy for ovarian cancer
Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook—surgery followed by chemotherapy—initially shows promise.